Current status and progress of 2019 novel coronavirus pneumonia
10.3760/cma.j.issn.2095-4352.2020.0006
- VernacularTitle: 2019年新型冠状病毒肺炎的研究现状与进展
- Author:
Xinying YANG
1
;
Congliang MIAO
2
;
Mengdi JIN
2
;
Dandan ZHOU
2
;
Jinqiang ZHUANG
2
;
Jiang HONG
2
Author Information
1. Shanghai General Hospital Affiliated to Nanjing Medical University, Shanghai 200080, China
2. Department of Emergency and Critical Care, Shanghai General Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200080, China
- Publication Type:Review
- Keywords:
2019 Novel coronavirus;
2019 Novel coronavirus pneumonia;
Current status;
Progress
- From:
Chinese Critical Care Medicine
2020;32(2):E006-E006
- CountryChina
- Language:Chinese
-
Abstract:
Recently, the 2019 novel coronavirus (2019-nCoV) pneumonia outbroke in Wuhan and rapidly spread to all over China and even the world. Because of the strong infectivity and various clinical symptoms, it has brought certain difficulties to the epidemic prevention and control. Currently there is no specific drug for 2019-nCoV. Previous drugs used to treat other coronaviruses may be effective, but further clinical trials remain needed. We reviewed literature on the epidemiology, etiology, clinical manifestations, imaging manifestations, laboratory examination, diagnosis, complications, treatment and outcome of 2019-nCoV pneumonia.
